These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 22125159)

  • 1. Hepatitis C virus--T-cell responses and viral escape mutations.
    Petrovic D; Dempsey E; Doherty DG; Kelleher D; Long A
    Eur J Immunol; 2012 Jan; 42(1):17-26. PubMed ID: 22125159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between the hepatitis C virus and the immune system.
    Rehermann B
    Semin Liver Dis; 2000; 20(2):127-41. PubMed ID: 10946419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evasion of host immune surveillance by hepatitis C virus: potential roles in viral persistence.
    Moorman JP; Joo M; Hahn YS
    Arch Immunol Ther Exp (Warsz); 2001; 49(3):189-94. PubMed ID: 11478392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
    Bode JG; Brenndörfer ED; Häussinger D
    Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
    Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
    J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes.
    Komatsu H; Lauer G; Pybus OG; Ouchi K; Wong D; Ward S; Walker B; Klenerman P
    J Viral Hepat; 2006 Feb; 13(2):121-30. PubMed ID: 16436130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection.
    Gaudieri S; Rauch A; Park LP; Freitas E; Herrmann S; Jeffrey G; Cheng W; Pfafferott K; Naidoo K; Chapman R; Battegay M; Weber R; Telenti A; Furrer H; James I; Lucas M; Mallal SA
    J Virol; 2006 Nov; 80(22):11094-104. PubMed ID: 17071929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.
    Torresi J; Johnson D; Wedemeyer H
    J Hepatol; 2011 Jun; 54(6):1273-85. PubMed ID: 21236312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection.
    Miles JJ; Thammanichanond D; Moneer S; Nivarthi UK; Kjer-Nielsen L; Tracy SL; Aitken CK; Brennan RM; Zeng W; Marquart L; Jackson D; Burrows SR; Bowden DS; Torresi J; Hellard M; Rossjohn J; McCluskey J; Bharadwaj M
    J Immunol; 2011 Jan; 186(2):901-12. PubMed ID: 21160049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Success and failure of virus-specific T cell responses in hepatitis C virus infection.
    Neumann-Haefelin C; Thimme R
    Dig Dis; 2011; 29(4):416-22. PubMed ID: 21894013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms.
    Krishnadas DK; Ahn JS; Han J; Kumar R; Agrawal B
    Int Immunol; 2010 Jun; 22(6):491-502. PubMed ID: 20410260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune evasion mechanisms of hepatitis C virus. Review].
    Porto-Espinoza L; Cuadra-Sánchez C; Moronta R; Monsalve-Castillo F; Callejas-Valero D
    Invest Clin; 2006 Mar; 47(1):71-82. PubMed ID: 16562646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathogenesis in hepatitis C virus cirrhosis.
    Spengler U; Nattermann J
    Clin Sci (Lond); 2007 Feb; 112(3):141-55. PubMed ID: 17199558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV-related hepatocellular carcinoma: From chronic inflammation to cancer.
    Castello G; Scala S; Palmieri G; Curley SA; Izzo F
    Clin Immunol; 2010 Mar; 134(3):237-50. PubMed ID: 19910258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?
    Missale G; Cariani E; Ferrari C
    Dig Liver Dis; 2004 Nov; 36(11):703-11. PubMed ID: 15570998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence.
    Burke KP; Cox AL
    Immunol Res; 2010 Jul; 47(1-3):216-27. PubMed ID: 20066508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.